NCT06827132View on ClinicalTrials.gov

Observational Study Evaluate Pathology Practice Use Artificial Intelligence in Patient Suspected Lung and Breast Cancer

Not yet recruitingOBSERVATIONAL
Enrollment

600

Participants

Timeline

Start Date

March 15, 2025

Primary Completion Date

May 31, 2027

Study Completion Date

May 31, 2027

Conditions
Lung CancerBreast Cancer
Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY